Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Investigating the effects of placebo on stroke recovery

Official title: Mechanisms of Open and Hidden Placebo in Stroke Recovery

Run by Spaulding Rehabilitation Hospital · NCT05832567 · Data updated 2026-11-12

This study is testing how different types of placebo treatments can help people recovering from a stroke feel better and improve their brain function.

More Stroke trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment56 (estimated)
SponsorSpaulding Rehabilitation Hospital
Academic / other
Locations1 site (Cambridge, Massachusetts)
StatusRecruiting
StartedSeptember 11, 2023
Main results expectedJune 1, 2026
Study endsDecember 30, 2026
Registry record updatedJuly 14, 2026
Trial IDNCT05832567 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 or older with hemiparesis due to chronic stroke lasting six months or more.

Probably not a fit

Patients with specific contraindications to TMS or those with severe depression may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial aims to explore the specific neural signatures associated with open and hidden placebo effects in individuals recovering from stroke. By examining how these placebo effects influence brain excitability and connectivity, the study seeks to enhance rehabilitation therapies for stroke patients. A total of 56 chronic stroke participants will be randomized into four groups to receive either open placebo, sham rTMS, no intervention, or active rTMS over a two-week period. The findings could provide critical insights into the role of placebo in stroke recovery and improve clinical outcomes.

Why it matters

Potential benefit: If successful, this study could lead to improved rehabilitation strategies for stroke patients by leveraging the placebo effect.

How similar studies have gone: While the placebo effect has been studied in various contexts, this specific investigation into its neural mechanisms in stroke recovery is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adults with hemiparesis due to chronic stroke
2. Stroke duration of 6 months or more
3. Fugl-Meyer scale upper extremity motor assessment score of \> 11 and ≤ 56
4. Pre-stroke disability (defined as a score of \< 3 on the Modified Rankin Scale)
5. Age 18 or older

Exclusion Criteria:

1. Stroke of anterior cerebral artery territory with prefrontal lesion and stroke-related decreased EEG power in the prefrontal cortex
2. Unable to understand instructions
3. TMS contraindications: electronic hardware in close contact to the discharging coil such as cochlear implant, internal pulse generator or medical pump
4. Concurrent unstable medical conditions
5. A score of 24 or higher on the Hamilton Depression Rating Scale (HDRS)
6. Joint or paretic extremity pain likely to interfere with assessments
7. Pregnancy

Where it's running

  • Spaulding Hospital Cambridge
    Cambridge, Massachusetts, United States
    Recruiting

Study contacts

  • Principal investigator: Felipe Fregni, MD, PhD, MPH — Spaulding Rehabilitation Hospital/Harvard Medical School
  • Study coordinator: Felipe Fregni, MD, PhD, MPH
  • Email: fregni.felipe@mgh.harvard.edu
  • Phone: 6179526156

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.